Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities-Reference-Cited by-同舟云学术

Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities

Published:2021-07-14 Issue:21 Volume:27 Page:5939-5950
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Chua Khi Pin^ORCID,Teng Yvonne H.F.,Tan Aaron C.^ORCID,Takano Angela^ORCID,Alvarez Jacob J.S.,Nahar Rahul,Rohatgi Neha,Lai Gillianne G.Y.,Aung Zaw Win,Yeong Joe P.S.,Lim Kiat Hon,Naeini Marjan Mojtabavi^ORCID,Kassam Irfahan^ORCID,Jain Amit,Tan Wan Ling,Gogna Apoorva,Too Chow Wei,Kanesvaran Ravindran^ORCID,Ng Quan Sing,Ang Mei Kim,Rajasekaran Tanujaa,Anantham Devanand^ORCID,Phua Ghee Chee,Tan Bien Soo^ORCID,Lee Yin Yeng,Wang Lanying^ORCID,Teo Audrey S.M.,Khng Alexis Jiaying^ORCID,Lim Ming Jie,Suteja Lisda^ORCID,Toh Chee Keong,Lim Wan-Teck^ORCID,Iyer N. Gopalakrishna,Tam Wai Leong^ORCID,Tan Eng-Huat,Zhai Weiwei,Hillmer Axel M.^ORCID,Skanderup Anders J.,Tan Daniel S.W.

Funder

National Medical Research Council

NMRC

National Research Foundation

CDAP

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors;The Journal of Pathology: Clinical Research;2024-01-17

2. Primary Resistance to EGFR Tyrosine Kinase Inhibitors (TKIs): Contexts and Comparisons in EGFR-Mutated Lung Cancer;Journal of Respiration;2023-12-13

3. Brief Report: circRUNX1 as Potential Biomarker for Cancer Recurrence in EGFR Mutation-Positive Surgically Resected NSCLC;JTO Clinical and Research Reports;2023-12

4. Allelic Context of EGFR C797X–Mutant Lung Cancer Defines Four Subtypes With Heterogeneous Genomic Landscape and Distinct Clinical Outcomes;Journal of Thoracic Oncology;2023-11

5. Integrated analysis of EGFR mutated non‐small cell lung cancer reveals two distinct molecular subtypes;Clinical and Translational Medicine;2023-10